Metraipolis › archive › dc_08d1cfd8f09b
Neurofilament light chain (NfL) as a surrogate outcome measure for GM2 gangliosidoses — Europe PMC PMID:42467089
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42467089
- DOI
- 10.1007/s00415-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T04:28:17.656Z
- SHA-256 of the archived text
b239fdca34cdbe95ef29a975d8965f68eb1fb5bcb4762a7bc2ab7909414d5bd6- Stable URL of this page
https://metraipolis.com/documento/dc_08d1cfd8f09b
How to cite
Neurofilament light chain (NfL) as a surrogate outcome measure for GM2 gangliosidoses — Europe PMC PMID:42467089 — Europe PMC (en), https://europepmc.org/article/MED/42467089 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08d1cfd8f09b (Metraipolis archive dc_08d1cfd8f09b, sha256 b239fdca34cdbe95ef29a975d8965f68eb1fb5bcb4762a7bc2ab7909414d5bd6)
BibTeX
@misc{dc08d1cfd8f09b,
title = {Neurofilament light chain (NfL) as a surrogate outcome measure for GM2 gangliosidoses — Europe PMC PMID:42467089},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42467089},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08d1cfd8f09b; sha256 b239fdca34cdbe95ef29a975d8965f68eb1fb5bcb4762a7bc2ab7909414d5bd6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42467089. Agents can read the archived copy with the MCP tool read_document.